key: cord-0986921-tcnhorpd
authors: Fredriksson, Mio
title: Patient and public involvement in the build‐up of COVID‐19 testing in Sweden
date: 2022-03-07
journal: Health Expect
DOI: 10.1111/hex.13463
sha: 8b1faeee1f935cd8d92e6d8bf49c695c8ca789f4
doc_id: 986921
cord_uid: tcnhorpd

BACKGROUND: Patient and public involvement in healthcare can be particularly challenging during crises such as the COVID‐19 pandemic. OBJECTIVE: The aims of the study, which focuses on COVID‐19 testing in Sweden, were to explore (1) how, or to what extent, patients and members of the public were involved in decisions about the organization of COVID‐19 testing during the first year of pandemic and (2) whether this was seen as feasible or desirable by regional and national stakeholders. METHODS: A qualitative interview study was conducted with key organizational stakeholders at three national agencies and within three Swedish regions (n = 16). RESULTS: There had been no patient and public involvement activities in the area of COVID‐19 testing. The regions had, however, tried to respond to demands or critiques from patients and the public along the way and to adapt the services to respond to their preferences. The need for rapid decision‐making, the uncertainty about whom to involve, as well as a hesitation about the appropriateness of involving patients and the public contributed to the lack of involvement. CONCLUSION: Future studies on patient and public involvement during crises should address what structures need to be in place to carry out involvement successfully during crises and when to use activities with varying degrees of power or decision‐making authority for patients and members of the public. PATIENT OR PUBLIC CONTRIBUTION: Fifteen members of the public contributed with short reflections on the study findings.

simultaneously constitutes a challenge to public involvement. In line with this, it was noticed in the United Kingdom a few months into the pandemic that, in the rush to introduce new COVID-19 policies and make service reconfigurations, patient and public consultation had largely been bypassed. 4 Mouter et al. 5 also noticed an absence of public involvement in decision-making about measures to curb the spread of the virus in the Netherlands. At the same time, it has been argued that patient involvement is the most powerful weapon to fight COVID-19, 6 that patients and members of the public should be involved in difficult discussions and decision-making processes regarding prioritization and treatment allocations during the pandemic, 7 and that an inclusive approach dealing with COVID-19 should be based on the empowerment of communities. 8 Although involving the public in policymaking during a crisis may be particularly challenging, there are a range of rationales for doing so according to Mouter et al. 5 They present substantive, normative, and instrumental justifications for public involvement in crisis policymaking. The substantive rationale suggests that public involvement will improve the quality of decisions. Input through a participatory process can align decisions with the public's preferences and the public may contribute with ideas, arguments, and values outside of the decision-makers' radar. The normative rationale suggests that public involvement is morally right because citizens (i.e., the public) should be able to make their voice heard in decisions that are of importance for their lives and for the community. It has been argued that health emergency policies should be participatory since they are 'deeply affecting people in very sensitive domains' 5 (p. 3) . Lastly, the instrumental rationale implies that the aim is to achieve a particular predefined end, for instance increasing the acceptance of certain policies (such as when to get tested for COVID -19) , which in turn can increase compliance.

This article focuses on patient and public involvement (PPI) in COVID-19 testing. Along with measures such as social distancing, the main pillars of the COVID-19 public health response in Europe during 2020 were robust testing capacity with prompt isolation of cases, contact tracing, and quarantine of identified contacts. 9 testing was considered crucial to mitigate the impact of the pandemic on vulnerable populations and healthcare systems, and to ensure the continued functioning of societies and economies. 10 The European

Centre for Disease Prevention and Control (ECDC) stressed that COVID-19 testing strategies should be flexible, and before implementing any population-wide testing strategy, it was important to consider factors such as transmission, costs, logistics, and barriers to testing. 9 The ECDC encouraged that testing efforts were maximized from June 2020. 11 One of the countries that had a rather slow increase in the testing capacity per 100,000 inhabitants during 2020 was Sweden, 12 which also differed compared to their neighbors in pandemic response. Overall, the 21 self-governing regions responsible for funding and provision of healthcare followed the recommendations issued by the Public Health Agency of Sweden (PHA) for whom to test for the COVID-19 infection. In early 2020, only certain individuals were tested (e.g., people coming from particular areas abroad). Between mid-March and June, COVID-19 testing was expanded to inpatients at hospitals, individuals belonging to a risk group, residents in care and in institutions, and health-and social care staff. It was only from mid-June 2020 that the 21 regions offered tests to all members of the population with symptoms (population-wide testing). Largely, the regions have been free to organize their testing systems according to local conditions, and, for example, some regions have offered home tests and drop-in tests, while others have not. From June 2020, the regions had financial support from the government. In the last week of May 2020, 36,466 individuals were tested in Sweden compared to 232,114 individuals in the last week of 2020.

The aims of the study, which focuses on COVID-19 testing in Sweden, were to explore (1) how, or to what extent, patients and members of the public were involved in decisions about the organization of COVID-19 testing during the first year of pandemic and (2) whether this was seen as feasible or desirable by regional and national stakeholders.

As the regions are self-governing, in practice, there are 21 regional health systems in Sweden and they differ in their organizational set-up and how they carry out PPI. There are no national policy documents that prescribe how PPI should be carried out (or that it should take place) in the service-provision part of the organization.

There is however an increasing consensus about the need to make healthcare more person-centered and the Patient Law (2014:821) establishes that the care patients receive should as far as possible be decided on and carried out in consultation with the patient. 13 At large, public involvement is channeled through the regions' democratic system, and the Municipal Act (2017:725) establishes that the political committees in the regions should strive to consult the service users. 14 Thus, public involvement betweenis desirable but not a requirement.

This is a qualitative interview study that draws on individual semistructured interviews with organizational stakeholders responsible for the build-up of COVID-19 testing in Sweden during 2020. Interviews were chosen because of the potential to gain a deeper understanding of experiences, attitudes, and processes linked to PPI in COVID-19 testing. 15 

As the interviews were carried out during the third wave (February-April 2021) and health professionals and managers had a heavy workload, we concentrated on three of the regions where it was possible to recruit participants. The three regions vary in geographical and population size, which allowed for a range of potential experiences, but the regions were hit by a more extensive spread of COVID-19 roughly at the same time and thus experienced the same high pressure to offer COVID-19 testing. The sample consists of 16 interviews with a range of key organizational stakeholders in the build-up of COVID-19 testing in these regions, as well as key representatives at three national authorities (see details in Table 1 ). In the selected regions all invited participants agreed to participate (sometimes after one or two reminders), while two declined at the national level. The sample is narrow in the sense that it only captures PPI in relation to COVID-19 testing. The interviews were conducted by the author and a doctoral student, who both have were again briefly informed about the study and signed a consent form to participate. The study was approved by the Swedish Ethical Review Authority (2020-05732).

The interviews were transcribed verbatim and analyzed thematically.

Under the main themes of conducted activities, feasibility, and desirability of PPI during the COVID-19 pandemic an inductive thematic analysis was carried out. 16 The author conducted the analysis and discussed and validated the results together with the doctoral student involved in data collection. A respondent responsible for testing in a region said that they had decided how to structure the COVID-19 testing service in their region without consulting potential users (we have not asked people

The physician responsible for disease control in the region (sve. smittskyddsläkare)

These physicians have an overall responsibility for disease control within the region. They plan, organize, and lead the work, for example ensuring that the public has the information it needs to protect themselves against infectious diseases. They also give advice to particularly vulnerable groups, and support healthcare staff.

Physicians responsible for COVID-19 testing The testing system and the organization of testing differ between the regions. We interviewed the personnel in charge of each region's system.

Representatives at the region's central communications unit

The organization of communications differs between the regions. We interviewed key people at the information/communication units in each region.

#8, #9, #10

From June, the county administrative boards were assigned by the government to assist the regions in the build-up of testing capacity and in performing tests.

Representative from the Public Health Agency of Sweden (PHA)

The PHA has a national responsibility for public health issues and works to ensure good public health. The agency also works to ensure that the population is protected against communicable diseases and other health threats.

Representative from the Swedish Association of Local Authorities and Regions (SALAR)

SALAR is an employers' organization which represents and advocates for local government in Sweden. All of Sweden's municipalities and regions are members of SALAR. Another type of uncertainty around involvement concerned who should be involved, which some of the respondents said that they did not see clearly, since COVID-19 is a disease affecting everybody. One of the respondents responsible for COVID-19

testing said that there was no user organization to talk to because it concerned everyone, and that they did not see whom they could have involved: 'I don't know: who would be the discussion partner except for the politicians?' (#6). The same respondent mentioned that they had been in close contact with the politicians in charge, which he/she saw as the extended arm of the members of the public.

The third type of hesitation expressed by some of the respondents regarded the participants' contribution. 

To improve the interpretation and understanding of the results, a number of members of the public were invited to contribute with an individual short reflection on the study findings, that is, that no PPI was carried out, and the reasons given by the national and regional stakeholders. Twenty members of the public were invited through contacts in the three regions and an invitation was also conveyed in a group of patients engaged in another type of PPI activity. In total, 15 individuals, aged between 18 and 83 years and living in rural as well as urban parts of the three regions, contributed in a telephone conversation or by written reflections.

Overall, the members of the public expressed an understanding that the lack of time did not make PPI possible. tested (particularly concerning school children), the number and location of testing stations, and whether the region offered home tests or not.

Some of the members of the public thought that it was less understandable that those responsible in the three regions did not know whom to involve and did not already have established channels for consulting patients and members of the public. This signaled that they were not used to involving patients or members of the public.

A man in his 30s expressed that it was worrying from a democratic point of view and several of the members of the public mentioned that there must have been opportunities to quickly consult with, at least, some patient organization. A man in his 70s thought the regions should use some digital solution to be able to quickly survey the public's opinions and a woman around the age of 20 hoped that the regions would improve their PPI after the pandemic.

Most studies on PPI at the levels of organizational design and governance, or policymaking, investigate particular PPI activities or PPI fora, for example how they work, who is represented, and their impact. In this article, however, PPI in the decisions about the organization of COVID-19 testing in Sweden was investigated-a service that did not exist before the pandemic but which was emphasized as crucial for a country's COVID-19 response by the WHO and the ECDC. 10, 17 This means how PPI, in general, has been carried out in the Swedish regions during the pandemic was not explored.

Overall, the interviews show that there had been no PPI in the build-up of the COVID-19 testing system in the three regions being the focus of the study. Similarly, in a scoping review, Cadel et al. 18 found few examples of involvement in organizational level decision making (design of care) during the first 6 months of the COVID-19

pandemic. The regions had, however, tried to respond to demands or critique from patients and the public along the way and to adapt the services to meet their preferences. Thus, in terms of the continuum of engagement, or involvement, described by Carman et al., 19 there had been no planned consultation and thus no structured opportunity for patients or members of the public to express views or contribute with opinions on the build-up and expansion of COVID-19 testing, which is considered to be the lowest end of the continuum.

Information is often added to this continuum, and our results show that the three regions and the national authorities had worked rather extensively to communicate their message to patients and members of the public, for example about when and how to be tested for COVID-19. There had been specific efforts to communicate with 'hard-to-reach'-groups not speaking Swedish and that are generally difficult to reach with messages from authorities because of relatively low levels of literacy and being outside the labor market.

The main reason why the respondents thought it was not feasible to involve patients and the public in the build-up and organization of COVID-19 testing was the need to make decisions quickly (time being a PPI facilitation barrier). 20 This corresponds with literature predicting a contraction of decision-making authority to speed up processes during a crisis, which constitutes a challenge to public involvement. 2 The lack of time during a crisis makes it difficult to give participants the proper training and support, which has been pointed out as necessary for successful involvement. 21, 22 All members of the public reflecting on the study findings however accepted that the lack of time was an obstacle.

Another reason why involvement was difficult was that the professionals being responsible for setting up the systems did not know whom to involve, since there was no particular patient group that was affected, and they had no established forum of patients or members of the public to consult. They did not see testing as an issue

to discuss with patient organizations as it was not patient-specific.

Uncertainties about practicalities and the imprecise role of patients and the public is another facilitation barrier described in the literature, 20 and it has been suggested that it may be advisable to have a citizen jury institutionalized as part of a public health response plan. 23 Similarly, one respondent wished they had already established a panel of 'ordinary' members of the public that they could rapidly assemble, and when reflecting on the study findings several members of the public expressed some concern that such channels did not exist.

In addition, there was some hesitation about the desirability of PPI in these types of decisions during a crisis. Some organizational stakeholders expressed a positive attitude to PPI more broadly whereas others expressed more of a restrictive approach, also sharing a concern for opening up for too much self-interest in important decisions. 24 There was also some hesitation about the participants' potential contribution, although involvement could be seen as important to investigate factors such as logistics and barriers to testing, which the ECDC stated should be considered before implementing any population-wide COVID-19 testing strategy. 9 A perceived superiority of professional knowledge 25 could also be detected in some of the respondents. The same beliefs and reliance on expert knowledge were also expressed by some of the members of the public when reflecting on the study findings.

Hickey and Chambers 26 have suggested that involvement challenges are related to the cultures of organizations and their processes and to professional identity (professionals may feel that their role will be undermined). 27 Nevertheless, it has been argued that without PPI 'researchers and clinicians may ultimately miss the needs deemed as high priority by the end users', 20 

There was no PPI in the build-up of the COVID-19 testing service in Sweden during the first year of the pandemic although there are substantive, normative, and instrumental justifications for involvement during crises. However, service adaptions were made as a response to incoming communication from patients and members of the public. The need for rapid decision-making, the uncertainty about whom to involve, and hesitation about the appropriateness of PPI and its contribution were reasons for the lack of PPI. Thus, in Sweden PPI is 'still largely seen as "nice to have", but not essential'. 7 Future studies on PPI during crises should address what structures need to be in place to carry out PPI successfully during crises and when to use activities with varying degrees of power or decision-making authority for patients and members of the public.

Enhancing crisis leadership in public health emergencies

Decision processes during crisis response: an exploratory investigation

Community engagement in a time of confinement

The views of patients and the public should be included in policy responses to covid-19

Public participation in crisis policymaking. How 30, 000 Dutch citizens advised their government on relaxing COVID-19 lockdown measures

Our most powerful weapon to fight COVID-19: patient involvement

Patient and public involvement in covid-19 policy making

New development: managing the Covid-19 pandemic-from a hospital-centred model of care to a community co-production approach

European Centre for Disease Prevention and Control. Population-wide testing of SARS-CoV-2: country experiences and potential approaches in the EU/EEA and the United Kingdom

European Centre for Disease Prevention and Control. COVID-19 testing strategies and objectives

European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK-tenth update

The territorial impact of COVID-19: managing the crisis across levels of government

Conducting research interviews

Using thematic analysis in psychology

World Health Organization. Laboratory testing strategy recommendations for COVID-19

A scoping review of patient engagement activities during COVID-19: more consultation, less partnership

Patient and family engagement: a framework for understanding the elements and developing interventions and policies

Patient and public engagement in priority setting: a systematic rapid review of the literature

Patient and family engagement in the ICU untapped opportunities and underrecognized challenges

Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs

The role of citizens in times of an epidemic or pandemic

The public is too subjective': public involvement at different levels of health-care decision making

How helpful are patient and public involvement strategic documents-results of a framework analysis using 4Pi National Involvement Standards

Patient and public involvement and engagement: mind the gap

Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews

In the works: patient and public involvement and engagement in healthcare decision-making

Adapting patient and public involvement in patient-oriented methods research: reflections in a Canadian setting during COVID-19

The Evolution and Everyday Practice of Collective Patient Involvement in Europe: An Examination of Policy Processes, Motivations, and Implementations in Four Countries

How to cite this article: Fredriksson M. Patient and public involvement in the build-up of COVID-19 testing in Sweden

The author would like to thank the respondents for taking part in the study despite their pressured work situation during the COVID-19pandemic. The author would also like to thank Ph.D. student Anna Hallberg for her great work when conducting the interviews. The study was funded by The Swedish Research Council for Health, Working Life and Welfare (2018-01578).

No data were available.

https://orcid.org/0000-0002-3858-3454